HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in rectal carcinoma.

AbstractOBJECTIVE:
In cancer patients, the balance between neutrophil (N) and lymphocyte (L) cell counts fluctuates with advancing disease. The objective of our study was to determine the prognostic implications of the N/L ratio in the peripheral blood of rectal cancer patients.
METHODS:
Study participants were identified from a prospective cohort of patients with rectal cancer in Dalian of China (n = 123).
RESULTS:
The median baseline N/L ratio was 2.41 +/- 2.206 (range, 0.76-20.45). Our results revealed that the N/L ratio was significantly associated with tumor size (P = 0.003) and level of cancer antigen 125 (P = 0.027). A multivariate Cox model established a significant relationship between the N/L ratio and survival (adjusted hazard ratio, 2.615; 95% confidence interval, 1.152-5.933; P = 0.021).
CONCLUSIONS:
These results suggest that the N/L ratio is an independent prognostic factor in rectal cancer, and the N/L ratio may serve as a clinically accessible and useful biomarker for patient survival.
AuthorsHuanran Liu, Ge Liu, Quan Bao, Wei Sun, Haidong Bao, Liang Bi, Wei Wen, Yanfeng Liu, Zhenglin Wang, Xunguo Yin, Yunqing Bai, Xiang Hu
JournalJournal of gastrointestinal cancer (J Gastrointest Cancer) Vol. 41 Issue 2 Pg. 116-20 (Jun 2010) ISSN: 1941-6636 [Electronic] United States
PMID20127292 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • China (epidemiology)
  • Cohort Studies
  • Female
  • Humans
  • Lymphocyte Count
  • Lymphocytes
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Neutrophils
  • Prognosis
  • Proportional Hazards Models
  • Prospective Studies
  • Rectal Neoplasms (blood, classification, mortality, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: